At BIOTRONIK, we are committed to helping people with heart and blood vessel diseases live healthy, fulfilling lives. This immense responsibility motivates thousands of employees worldwide to develop new cardiovascular and endovascular medical technologies that physicians trust to save and improve patient lives. Our unique, safe and reliable products, including pacemakers, stents, implantable defibrillators and remote monitoring services, help patients in more than 100 countries.

Follow on social Media
Orsiro® DES Animation
Orsiro® DES is the first and only ultrathin DES to outperform the clinical standard, Xience (1). Offering outstanding patient outcomes, excellent deliverability, and ultrathin struts. Orsiro is the only ultrathin strut drug-eluting stent in the US (2). - Kandzari D et al. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularization (BIOFLOW V): a randomized trial. The Lancet, 2017. - When compared to FDA approved Drug Eluting Stents. BIOTRONIK data on file.
Orsiro Overview
PK Papyrus Overview